A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Fluoroquinolone prophylaxis in patients with profound neutropenia may be useful for preventing gram-negative bacterial infection, but it is ineffective against gram-positive bacterial infections in the bloodstream, particularly those caused by streptococci and coagulase-negative staphylococci, which...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Kern, W V, Hay, B, Kern, P, Marre, R, Arnold, R
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1994
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284481/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203838/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.465
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!